Deep Track Capital’s Ambrx Biopharma Inc AMAM Stock Holding History
Bought
Maintained
Sold
Deep Track Capital's AMAM Position: Q1 2024 in Review
Deep Track Capital sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 3,710,412 shares — an estimated $52.8M sold.
Deep Track Capital first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $52.8M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.
- Deep Track Capital reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
- Deep Track Capital sold 3,710,412 Ambrx Biopharma Inc shares in Q1 2024, an estimated $52.8M.
- Deep Track Capital first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
- Deep Track Capital's Ambrx Biopharma Inc position peaked at $52.8M in Q4 2023.
- 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.
Based on Deep Track Capital's 13F filing for Q1 2024, filed 15 May 2024.